Viewing StudyNCT00470704



Ignite Creation Date: 2024-05-05 @ 5:32 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00470704
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-27
First Post: 2007-05-07

Brief Title: Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer
Sponsor: Nancy Lin MD
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
trastuzumab View
HER2-positive breast cancer View
Herceptin View